DK621487D0 - Fremgangsmaade til oegning af adenosinexkretion - Google Patents

Fremgangsmaade til oegning af adenosinexkretion

Info

Publication number
DK621487D0
DK621487D0 DK621487A DK621487A DK621487D0 DK 621487 D0 DK621487 D0 DK 621487D0 DK 621487 A DK621487 A DK 621487A DK 621487 A DK621487 A DK 621487A DK 621487 D0 DK621487 D0 DK 621487D0
Authority
DK
Denmark
Prior art keywords
procedure
excretion
increasing
increasing adenosine
adenosine excretion
Prior art date
Application number
DK621487A
Other languages
English (en)
Other versions
DK175693B1 (da
DK621487A (da
Inventor
Harry Edward Gruber
Original Assignee
Harry Edward Gruber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harry Edward Gruber filed Critical Harry Edward Gruber
Publication of DK621487D0 publication Critical patent/DK621487D0/da
Publication of DK621487A publication Critical patent/DK621487A/da
Priority to DK198904471A priority Critical patent/DK174934B1/da
Application granted granted Critical
Publication of DK175693B1 publication Critical patent/DK175693B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198706214A 1986-03-27 1987-11-26 Fremgangsmåde til ögning af adenosinexkretion DK175693B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK198904471A DK174934B1 (da) 1986-03-27 1989-09-11 Fremgangsmåde til screening af purinnucleosidforbindelser

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84562786A 1986-03-27 1986-03-27
US84562786 1986-03-27
US8600736 1986-04-08
PCT/US1986/000736 WO1987005807A1 (en) 1986-03-27 1986-04-08 A method of increasing adenosine excretion

Publications (3)

Publication Number Publication Date
DK621487D0 true DK621487D0 (da) 1987-11-26
DK621487A DK621487A (da) 1988-01-26
DK175693B1 DK175693B1 (da) 2005-01-24

Family

ID=25295693

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198706214A DK175693B1 (da) 1986-03-27 1987-11-26 Fremgangsmåde til ögning af adenosinexkretion

Country Status (9)

Country Link
EP (2) EP0623348A1 (da)
JP (1) JP2509202B2 (da)
AT (1) ATE135914T1 (da)
AU (3) AU5668886A (da)
BR (1) BR8607124A (da)
DE (1) DE3650505T2 (da)
DK (1) DK175693B1 (da)
FI (1) FI875245A0 (da)
WO (1) WO1987005807A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912092A (en) * 1986-03-27 1990-03-27 The Regents Of The University Of California Methods for increasing extracellular adenosine and for stabilizing mast cells
US5132291A (en) * 1989-01-24 1992-07-21 Gensia Pharmaceuticals, Inc. Antivirals and methods for increasing the antiviral activity of azt
JPH03504728A (ja) * 1989-01-24 1991-10-17 ジェンシア・ファーマシュウティカルズ，インコーポレイテッド Ａｉｃａリボシドの放出および血液グルコースの低減のための化合物および方法
IL103294A0 (en) * 1991-09-30 1993-05-13 Gensia Pharma Pharmaceutical compositions for preventing tissue damage associated with decreased blood flow
US5366960A (en) * 1993-08-26 1994-11-22 Warner-Lambert Company Method of treating cerebral and cardiovascular disorders employing [R]3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidaz 0-[4,5-d][1,3]diazepin-8-ol
CZ293584B6 (cs) * 1996-01-23 2004-06-16 Icn Pharmaceuticals Prostředek pro modulaci exprese lymfokinů
EP1174141A3 (en) * 1996-01-23 2003-04-23 ICN Pharmaceuticals, Inc. Modulation of TH1/TH2 cytokine expression by ribavirin and ribavirin analogs in activated t-lymphocytes
RU2169568C2 (ru) * 1998-07-14 2001-06-27 Омская государственная медицинская академия Средство для коррекции энергетического обмена
WO2000030656A1 (en) * 1998-11-20 2000-06-02 The Salk Institute For Biological Studies Neuron stimulation by ribavirin, and analogs thereof
US6680292B1 (en) 1998-11-20 2004-01-20 The Salk Institute For Biological Studies Pharmaceutical composition comprising ribavirin and growth factors and methods of use
CA2357735A1 (en) * 1999-01-29 2000-08-03 Icn Pharmaceuticals, Inc. Modulation of immune response by ribavirin
CZ20022112A3 (cs) * 1999-12-23 2003-05-14 Ribapharm Inc. Prostředky a způsoby, týkající se L-nukleosidů, L-nukleotidů, a jejich analog
AU2006230242B2 (en) 2005-03-28 2013-05-30 Pericor Therapeutics, Inc. Methods, compositions, and formulations for preventing or reducing adverse effects in a patient
EP1993564A4 (en) * 2006-03-14 2010-05-26 Wholesome Biopharma Pty Ltd METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES
EP2349284B1 (en) 2008-10-03 2016-11-23 Pericor Therapeutics, Inc. Treatment of acute decompensated heart failure

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US29835A (en) * 1860-08-28 Surveyor s instrument
US3798209A (en) * 1971-06-01 1974-03-19 Icn Pharmaceuticals 1,2,4-triazole nucleosides
US4211771A (en) * 1971-06-01 1980-07-08 Robins Ronald K Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
USRE29835E (en) * 1971-06-01 1978-11-14 Icn Pharmaceuticals 1,2,4-Triazole nucleosides
US3888843A (en) * 1973-06-12 1975-06-10 Toyo Jozo Kk 4-carbamoyl-1-' -d-ribofuranosylimidazolium-5-olate
US3923785A (en) * 1974-04-22 1975-12-02 Parke Davis & Co (R)-3-(2-deoxy-{62 -D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo{8 4,5-d{9 {8 1,3{9 diazepin-8-ol
US4163839A (en) * 1977-12-09 1979-08-07 Zaidan Hojin Biselbutsu Kagaku Kenkyu Kai Isocoformycin and a process for the production thereof
GB2016452B (en) * 1978-02-18 1982-07-21 Kissei Pharmaceutical Imidazole compounds
JPS5671075A (en) * 1979-11-12 1981-06-13 Sumitomo Chem Co Ltd Novel imidazole derivative
AU529815B2 (en) * 1981-05-15 1983-06-23 Fisons Plc Optically active imidazole derivatives
JPS59167515A (ja) * 1983-03-15 1984-09-21 Ajinomoto Co Inc 免疫機能増強剤
US4575498A (en) * 1983-07-21 1986-03-11 Duke University Method for restoring depleted purine nucleotide pools
JPH05334796A (ja) * 1992-06-02 1993-12-17 Sony Corp 光学式ディスク装置

Also Published As

Publication number Publication date
DE3650505T2 (de) 1996-09-19
EP0262125A4 (en) 1989-07-26
EP0262125A1 (en) 1988-04-06
DK175693B1 (da) 2005-01-24
JPS63503061A (ja) 1988-11-10
FI875245A7 (fi) 1987-11-27
DK621487A (da) 1988-01-26
EP0623348A1 (en) 1994-11-09
BR8607124A (pt) 1988-04-05
ATE135914T1 (de) 1996-04-15
JP2509202B2 (ja) 1996-06-19
WO1987005807A1 (en) 1987-10-08
FI875245L (fi) 1987-11-27
AU5198693A (en) 1994-02-03
DE3650505D1 (de) 1996-05-02
AU6006090A (en) 1990-11-08
EP0262125B1 (en) 1996-03-27
AU5668886A (en) 1987-10-20
FI875245A0 (fi) 1987-11-27
AU672243B2 (en) 1996-09-26

Similar Documents

Publication Publication Date Title
DK621487A (da) Fremgangsmaade til oegning af adenosinexkretion
DE3854741D1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DK0509019T3 (da) Behandling af humane retrovirale infektioner med 2',3'-dideoxyinosin
DK217188A (da) Farmaceutisk praeparat til behandling af neurologiske sygdomme
DK254887A (da) Salve til behandling af hudsygdomme
DK524788A (da) Anvendelse af morphin-antagonister til fremstilling af laegemidler med immunomodulerende og antiviral effekt, isaer til behandling af erhvervede immundefekt-tilstande
EP0283505A4 (en) Vaccine and method of preparation.
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
ATE65402T1 (de) Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
KR900700495A (ko) 치료제로서 유용한 치환된 아데닌 유도체
OA06951A (fr) Dérivés de la thiéno-pyridinone, leur procédé de préparation et leur application thérapeutique.
EP0259324A4 (en) Mastitis vaccine.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
DE69007065D1 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
EP0267297A4 (en) SIALOSYLCHOLESTEROL, PROCESS FOR THE PREPARATION AND MEDICINE AGAINST DISORDERS OF THE NERVOUS SYSTEM.
DK532087D0 (da) Farmaceutiske praeparater til behandling af hjernelidelser paa funktional og organisk basis
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
ES2091820T3 (es) 5-amino-carbonil-5h-dibenzo(a,d)ciclo-hepten-5.10-iminas para tratamiento de la epilepsia y la adiccion a la cocaina.
ATE59779T1 (de) Verfahren zur regulierung der tierischen fortpflanzung.
OA07133A (fr) Dérivés de benzoyl-phényl-pipéridine, procédé de préparation et application en thérapeutique.
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
SE8306384L (sv) Farmaceutisk komposition
DK639088A (da) Laegemiddel til behandling af iskaemiske hjertesygdomme

Legal Events

Date Code Title Description
PUP Patent expired